$MDXG
MIMEDX GROUP, INC.

2016 Q4 Form 10-Q Financial Statement

#000137633916000213 Filed on November 08, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q4
Revenue $69.88M $64.43M $51.84M
YoY Change 34.81% 31.45% 30.99%
Cost Of Revenue $7.690M $7.997M $4.990M
YoY Change 54.11% 60.61% 38.61%
Gross Profit $60.81M $56.43M $46.85M
YoY Change 29.79% 28.15% 30.23%
Gross Profit Margin 87.02% 87.59% 90.38%
Selling, General & Admin $41.81M $48.18M $36.52M
YoY Change 14.49% 38.04% 24.9%
% of Gross Profit 68.76% 85.38% 77.95%
Research & Development $5.760M $2.919M $2.340M
YoY Change 146.15% 33.47% 26.49%
% of Gross Profit 9.47% 5.17% 4.99%
Depreciation & Amortization $1.190M $838.0K $780.0K
YoY Change 52.56% 78.3% 36.84%
% of Gross Profit 1.96% 1.48% 1.66%
Operating Expenses $47.82M $51.10M $39.09M
YoY Change 22.33% 37.78% 24.81%
Operating Profit $12.99M $4.703M $7.759M
YoY Change 67.38% -29.95% 66.75%
Interest Expense -$90.00K -$90.00K -$70.00K
YoY Change 28.57% 800.0% 600.0%
% of Operating Profit -0.69% -1.91% -0.9%
Other Income/Expense, Net -$87.00K
YoY Change 1640.0%
Pretax Income -$8.930M $4.616M $7.680M
YoY Change -216.28% -31.2% 65.52%
Income Tax -$2.830M $1.295M -$5.700M
% Of Pretax Income 28.05% -74.22%
Net Earnings $5.481M $3.321M $13.38M
YoY Change -59.03% -49.31% 249.11%
Net Earnings / Revenue 7.84% 5.15% 25.81%
Basic Earnings Per Share $0.05 $0.03 $0.13
Diluted Earnings Per Share $0.05 $0.03 $0.11
COMMON SHARES
Basic Shares Outstanding 109.5M shares 106.0M shares 109.0M shares
Diluted Shares Outstanding 112.4M shares

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.40M $18.30M $31.50M
YoY Change 9.21% -61.55% -39.77%
Cash & Equivalents $30.32M $18.34M $26.30M
Short-Term Investments $0.00 $0.00 $3.000M
Other Short-Term Assets $9.516M $6.200M $215.0K
YoY Change 4326.05% 129.63% -85.67%
Inventory $15.87M $18.31M $7.460M
Prepaid Expenses $1.838M $3.394M
Receivables $1.927M $63.43M $53.76M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $59.47M $106.3M $96.31M
YoY Change -38.25% 3.45% 12.41%
LONG-TERM ASSETS
Property, Plant & Equipment $13.99M $13.76M $9.475M
YoY Change 47.6% 64.24% 73.95%
Goodwill $20.20M $26.95M $4.040M
YoY Change 400.07% 567.1% 0.0%
Intangibles $23.26M $27.25M $10.76M
YoY Change 116.09% 153.72% -0.76%
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $354.0K $7.400M $15.30M
YoY Change -97.69% 28361.54%
Total Long-Term Assets $57.80M $75.38M $39.60M
YoY Change 45.95% 225.14% 67.94%
TOTAL ASSETS
Total Short-Term Assets $59.47M $106.3M $96.31M
Total Long-Term Assets $57.80M $75.38M $39.60M
Total Assets $117.3M $181.7M $135.9M
YoY Change -13.71% 44.26% 24.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.44M $11.16M $6.633M
YoY Change 72.41% 54.09% 81.18%
Accrued Expenses $19.21M $6.664M $4.644M
YoY Change 313.59% 62.66% 85.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $60.79M $41.58M $26.78M
YoY Change 127.03% 70.74% 45.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $875.0K $832.0K $1.148M
YoY Change -23.78% -20.99% -24.77%
Total Long-Term Liabilities $875.0K $832.0K $1.148M
YoY Change -23.78% -20.99% -24.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $60.79M $41.58M $26.78M
Total Long-Term Liabilities $875.0K $832.0K $1.148M
Total Liabilities $69.21M $58.39M $27.93M
YoY Change 147.83% 129.83% 40.12%
SHAREHOLDERS EQUITY
Retained Earnings -$111.3M -$31.64M -$38.13M
YoY Change 191.92% -38.58% -43.58%
Common Stock $110.0K $110.0K $109.0K
YoY Change 0.92% 0.92% 0.93%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.216M $5.136M $17.13M
YoY Change -87.06% 23.64% 203.8%
Treasury Stock Shares 349.8K shares 699.8K shares 2.106M shares
Shareholders Equity $48.07M $123.3M $34.72M
YoY Change
Total Liabilities & Shareholders Equity $117.3M $181.7M $135.9M
YoY Change -13.71% 44.26% 24.4%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q4
OPERATING ACTIVITIES
Net Income $5.481M $3.321M $13.38M
YoY Change -59.03% -49.31% 249.11%
Depreciation, Depletion And Amortization $1.190M $838.0K $780.0K
YoY Change 52.56% 78.3% 36.84%
Cash From Operating Activities $14.70M $2.850M $4.360M
YoY Change 237.16% -61.01% -47.34%
INVESTING ACTIVITIES
Capital Expenditures -$1.230M -$1.740M -$1.910M
YoY Change -35.6% -5.95% 127.38%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $3.500M
YoY Change -100.0% -100.0% -138.89%
Cash From Investing Activities -$1.230M -$1.740M $1.590M
YoY Change -177.36% 58.18% -116.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 700.0K -6.580M -18.54M
YoY Change -103.78% 76.41% -2206.82%
NET CHANGE
Cash From Operating Activities 14.70M 2.850M 4.360M
Cash From Investing Activities -1.230M -1.740M 1.590M
Cash From Financing Activities 700.0K -6.580M -18.54M
Net Change In Cash 14.17M -5.470M -12.59M
YoY Change -212.55% -320.56% 1751.47%
FREE CASH FLOW
Cash From Operating Activities $14.70M $2.850M $4.360M
Capital Expenditures -$1.230M -$1.740M -$1.910M
Free Cash Flow $15.93M $4.590M $6.270M
YoY Change 154.07% -49.89% -31.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Period End Date
DocumentPeriodEndDate
2016-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001376339
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
109514557 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MIMEDX GROUP, INC.
CY2016Q3 mdxg Capital Leases Interest Rate Effective Percentage Maximum
CapitalLeasesInterestRateEffectivePercentageMaximum
0.12
CY2016Q3 mdxg Capital Leases Interest Rate Effective Percentage Minimum
CapitalLeasesInterestRateEffectivePercentageMinimum
0.03
mdxg Effective Income Tax Rate Reconciliation Increase Decrease During Period Amount
EffectiveIncomeTaxRateReconciliationIncreaseDecreaseDuringPeriodAmount
900000 USD
mdxg Effective Income Tax Rate Reconciliation Increase Decrease During Period Percent
EffectiveIncomeTaxRateReconciliationIncreaseDecreaseDuringPeriodPercent
0.283
CY2015Q4 mdxg Intangible Assets Accumulated Amortization And Impairment Charges
IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges
4864000 USD
CY2016Q3 mdxg Intangible Assets Accumulated Amortization And Impairment Charges
IntangibleAssetsAccumulatedAmortizationAndImpairmentCharges
6753000 USD
mdxg Number Of Share Based Compensation Plans
NumberOfShareBasedCompensationPlans
4 plan
mdxg Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
594000 USD
mdxg Paymentsfor Application Costs Patent
PaymentsforApplicationCostsPatent
515000 USD
mdxg Treasury Stock Brokerage Commissions
TreasuryStockBrokerageCommissions
40000 USD
mdxg Writeoffof Fixed Assets
WriteoffofFixedAssets
319000 USD
mdxg Writeoffof Fixed Assets
WriteoffofFixedAssets
0 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6633000 USD
CY2016Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11162000 USD
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
53755000 USD
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
63427000 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4644000 USD
CY2016Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6664000 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4979000 USD
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7373000 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
163133000 USD
CY2016Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
159940000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
892000 USD
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4378000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12564000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4701000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13826000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
136000 USD
CY2015Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
234000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
699000 USD
CY2016Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
631000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1889000 USD
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8044742 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7931984 shares
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6369189 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6265811 shares
CY2015Q4 us-gaap Assets
Assets
135913000 USD
CY2016Q3 us-gaap Assets
Assets
181665000 USD
CY2015Q4 us-gaap Assets Current
AssetsCurrent
96310000 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
106290000 USD
CY2015Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.04
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.11
CY2016Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.03
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.06
CY2015Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
4253000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
12227000 USD
CY2016Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
3406000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
7074000 USD
CY2015Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
52108000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-10148000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18338000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5509000 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
109000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
148521000 USD
CY2016Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
64429000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
175687000 USD
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 USD
CY2016Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
9642000 USD
CY2015Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 USD
CY2016Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
15978000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46582000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41073000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28486000 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109467416 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110212547 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107361471 shares
CY2016Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109512781 shares
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
110000 USD
CY2016Q3 us-gaap Contractual Obligation
ContractualObligation
9804000 USD
CY2016Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
550000 USD
CY2016Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
957000 USD
CY2016Q3 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
3156000 USD
CY2016Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
3103000 USD
CY2016Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
2038000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4979000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
15217000 USD
CY2016Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7997000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
23338000 USD
CY2015Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
487000 USD
CY2016Q3 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
399000 USD
CY2015Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14838000 USD
CY2016Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7019000 USD
CY2015Q3 us-gaap Depreciation
Depreciation
470000 USD
us-gaap Depreciation
Depreciation
1247000 USD
CY2016Q3 us-gaap Depreciation
Depreciation
838000 USD
us-gaap Depreciation
Depreciation
2394000 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P8Y
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
7631000 USD
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
87000 USD
us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
21000 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
4176000 USD
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.032
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.315
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15034000 USD
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10812000 USD
CY2016Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2150652 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
16396000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
630000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1805000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2075000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2075000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2430000 USD
CY2016Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
25411000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
4040000 USD
CY2016Q3 us-gaap Goodwill
Goodwill
26951000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
44036000 USD
us-gaap Gross Profit
GrossProfit
120244000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
56432000 USD
us-gaap Gross Profit
GrossProfit
151801000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6709000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
16595000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4616000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9477000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
158000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
527000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1295000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2984000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1506000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
637000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3747000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3941000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20106000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7671000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1592000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2020000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
1474000 USD
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
-4223000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
520000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3599000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
26000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
163000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1087000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2539000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1201000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2023000 USD
CY2015Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
15627000 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
5301000 USD
CY2016Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
34002000 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10763000 USD
CY2016Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
27249000 USD
us-gaap Interest Paid
InterestPaid
18000 USD
us-gaap Interest Paid
InterestPaid
118000 USD
CY2015Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3405000 USD
CY2016Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11118000 USD
CY2015Q4 us-gaap Inventory Gross
InventoryGross
7857000 USD
CY2016Q3 us-gaap Inventory Gross
InventoryGross
19021000 USD
CY2015Q4 us-gaap Inventory Net
InventoryNet
7460000 USD
CY2016Q3 us-gaap Inventory Net
InventoryNet
18313000 USD
CY2015Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
602000 USD
CY2016Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1193000 USD
CY2015Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
397000 USD
CY2016Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
708000 USD
CY2015Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3850000 USD
CY2016Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
6710000 USD
us-gaap Inventory Write Down
InventoryWriteDown
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
1500000 USD
us-gaap Inventory Write Down
InventoryWriteDown
1471000 USD
CY2015Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
363000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
956000 USD
CY2016Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
453000 USD
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1311000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
27925000 USD
CY2016Q3 us-gaap Liabilities
Liabilities
58388000 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
135913000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
181665000 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26777000 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
41578000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17690000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8849000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2270000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10447000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14451000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9148000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
6551000 USD
us-gaap Net Income Loss
NetIncomeLoss
16068000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
3321000 USD
us-gaap Net Income Loss
NetIncomeLoss
6493000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
6714000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
16613000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4703000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
9731000 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
466000 USD
CY2016Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3298000 USD
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1148000 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
832000 USD
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-18000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-87000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-254000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
10338000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
106000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
892000 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3609000 USD
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6212000 USD
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-21068000 USD
us-gaap Proceeds From Repurchase Of Equity
ProceedsFromRepurchaseOfEquity
-10378000 USD
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
2500000 USD
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
3000000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3465000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2548000 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14454000 USD
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21130000 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9475000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13757000 USD
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2187000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6072000 USD
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2919000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8582000 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38130000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31637000 USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
49015000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
135461000 USD
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
64429000 USD
CY2016Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
48179000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
131599000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
175139000 USD
CY2015Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34901000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
96860000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12564000 USD
CY2016Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
11818559 shares
CY2016Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
12962168 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
11818559 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.30
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.76
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.77
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.52
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
62449678 USD
us-gaap Share Based Compensation
ShareBasedCompensation
13826000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.581
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.544
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0168
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0151
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
12937248 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5283449 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
38354 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
93097 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
64153271 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
14019629 shares
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12962168 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.62
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.65
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
64120370 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y7M13D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y7M13D
CY2016Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
3.30
CY2016Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
3.65
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P5Y9M7D
CY2015Q4 us-gaap Short Term Investments
ShortTermInvestments
3000000 USD
CY2016Q3 us-gaap Short Term Investments
ShortTermInvestments
0 USD
us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
441009 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
16493 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
43344 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
926010 shares
us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
2854189 shares
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
0 USD
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
3346000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
164000 USD
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
346000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13826000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
123277000 USD
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
60000000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10000000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2548000 USD
us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
23257728 USD
CY2014Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000 USD
CY2016Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
3936000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
107988000 USD
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2105945 shares
CY2016Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
699766 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1338616 shares
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
17124000 USD
CY2016Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5136000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10378000 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-15400000 USD
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
8044742 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
7931984 shares
CY2016Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6369189 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6265811 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114556036 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114110120 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112361179 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
112193701 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106511294 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106178136 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105991990 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105927890 shares
us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revenue Recognition</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company sells its products through a combination of a direct sales force and independent stocking distributors and representatives in the U.S. and independent distributors in international markets. The Company recognizes revenue when title to the goods transfers to customers, provided there are no material remaining performance obligations required of the Company or any matters of customer acceptance. In cases where the Company utilizes distributors or ships product directly to the end user, it recognizes revenue upon shipment provided all other revenue recognition criteria have been met. A portion of the Company's revenue is generated from inventory maintained at hospitals, clinics and doctor's offices. For these products, revenue is recognized at the time the product has been used or implanted. The Company records estimated sales returns, discounts and allowances as a reduction of net sales in the same period revenue is recognized.&#160;&#160;</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.&#160;</font></div></div>

Files In Submission

Name View Source Status
0001376339-16-000213-index-headers.html Edgar Link pending
0001376339-16-000213-index.html Edgar Link pending
0001376339-16-000213.txt Edgar Link pending
0001376339-16-000213-xbrl.zip Edgar Link pending
exhibit311-certificationof.htm Edgar Link pending
exhibit312-certificationof.htm Edgar Link pending
exhibit321-certificationof.htm Edgar Link pending
exhibit322-certificationof.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mdxg-20160930.xml Edgar Link completed
mdxg-20160930.xsd Edgar Link pending
mdxg-20160930_cal.xml Edgar Link unprocessable
mdxg-20160930_def.xml Edgar Link unprocessable
mdxg-20160930_lab.xml Edgar Link unprocessable
mdxg-20160930_pre.xml Edgar Link unprocessable
mdxg-2016930x10xq.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending